News and commentary from the psychiatry world ...

A reduced risk for nonaffective psychosis was seen among individuals diagnosed in childhood (age younger than 13 years) in secondary analyses. HealthDay News — For ...

Experts found that children treated with methylphenidate before the age of 13 were less likely to go on to develop conditions such as schizophrenia in adulthood. The findings challenge long-standing ...

Researchers in the UK found no evidence that methylphenidate, the active ingredient in Ritalin, increases children's odds of later developing schizophrenia. Reading time 3 minutes No drug comes ...

A major new study has found that commonly prescribed medication for attention deficit hyperactivity disorder (ADHD) in childhood may not only be safe in the long term, but could also lower the risk of ...

Methylphenidate helps the brain to regulate focus and impulse control. It is the most commonly used medicine for ADHD and is the active substance in Concerta, Ritalin, Medikinet and other medicines.

Attention deficit and hyperactivity disorder (ADHD) affects 5% to 7% of schoolgoing children, but because doctors can only prescribe treatment for a month at a time, many children in South Africa, ...

The presence of dysregulation profile in children with ADHD was associated with higher sleep disturbances following treatment with methylphenidate. Children with ...

Methylphenidate is the most-used medication for ADHD worldwide, prescribed more than 17 million times in the U.S. alone in 2023. Credit: Photo by Jaap Arriens/NurPhoto Shocking (extra jazz hands).

In a study that was originally published late last year, researchers unveiled the risks for former cocaine users who may relapse by taking methylphenidate. Methylphenidate is used as a treatment for ...

The Journal of Clinical Oncology podcast, hosted by Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.

Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer This is a randomized, ...